The world's first mass-market gene therapy has been legalized in Europe. Glybera, which treats a painful disorder that leads to pancreatitis, will be available in hospitals beginning next year.
If you've ever had the sneaking suspicion that the so-called halibut on your plate might be a sea bass in disguise, it turns out your hunch was right. A large-scale seafood investigation found that unscrupulous fishermen and vendors mislabel an average of half of all fish sold, negatively impacting shoppers' wallets and health--not to mention marine conservation.
What's the difference between a multi-billion-dollar startup and a flop? The Startup Genome Project, an initiative started by the Silicon Valley-based blackbox seed accelerator, is taking on the task of decoding what makes a startup succeed by breaking down the individual attributes of successful companies into a definable taxonomy.
A microbe found in a Californian lake is alive but its DNA includes a different material to everything else living on Earth: Arsenic. It's proof positive, says NASA, that E.T. is out there.
